Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial of Approaches to Prostate Cancer Surgery
Sponsor: Weill Medical College of Cornell University
Summary
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
Official title: Clinical TrIAL of Approaches to Prostate cAncer suRgery
Key Details
Gender
MALE
Age Range
40 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2023-05-15
Completion Date
2028-07
Last Updated
2026-04-22
Healthy Volunteers
No
Conditions
Interventions
Robot-assisted radical prostatectomy (RP)
The conventional approach to prostate cancer surgery
Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP)
A novel, posterior approach to radical prostatectomy that preserves the dorsal vascular complex, nerves and fascial support structures that overlie the anterior prostate.
Locations (9)
Beckman Research Institute of City of Hope
Duarte, California, United States
Georgetown University
Washington D.C., District of Columbia, United States
Northwestern University
Chicago, Illinois, United States
Johns Hopkins University
Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts, United States
Hackensack Meridian Health
Hackensack, New Jersey, United States
NewYork-Presbyterian Queens
Flushing, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Weill Cornell Medicine
New York, New York, United States